Continuous Manufacturing of Pharmaceuticals 2017
DOI: 10.1002/9781119001348.ch12
|View full text |Cite
|
Sign up to set email alerts
|

Design of an Integrated Continuous Manufacturing System

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 50 publications
0
4
0
Order By: Relevance
“…Mean residence time describes the amount of time an average particle will spend within a process/unit operation(s). For an RTD model, assuming negligible non-ideality such as dead volume in the system, the mean residence time within a unit operation may be expressed in terms of space time, which is defined as a ratio of the mass holdup in the unit operation and overall line mass throughput (42,43). Therefore, the RTD model can account for the dynamics of mass holdup and mass throughput.…”
Section: Description Of Rtd-based Flowsheet Modeling Frameworkmentioning
confidence: 99%
“…Mean residence time describes the amount of time an average particle will spend within a process/unit operation(s). For an RTD model, assuming negligible non-ideality such as dead volume in the system, the mean residence time within a unit operation may be expressed in terms of space time, which is defined as a ratio of the mass holdup in the unit operation and overall line mass throughput (42,43). Therefore, the RTD model can account for the dynamics of mass holdup and mass throughput.…”
Section: Description Of Rtd-based Flowsheet Modeling Frameworkmentioning
confidence: 99%
“…Traditional pharmaceutical oral dosage manufacturing is carried out in a series of batch unit operations. In the past 10 years, the pharmaceutical industry has been transitioning the manufacturing of a number of products from traditional batch processes to continuous processes due to the improved agility, flexibility, and robustness in continuous operation . There is a large amount of existing “know‐how” for batch pharmaceutical processes, and batch manufacturing can offer advantages over continuous manufacturing for products that are produced in small quantities.…”
Section: Introductionmentioning
confidence: 99%
“…In the past 10 years, the pharmaceutical industry has been transitioning the manufacturing of a number of products from traditional batch processes to continuous processes due to the improved agility, flexibility, and robustness in continuous operation. 1 There is a large amount of existing "knowhow" for batch pharmaceutical processes, and batch manufacturing can offer advantages over continuous manufacturing for products that are produced in small quantities. However, once large quantities of a product are required, a continuous process allows for a smaller footprint and smaller equipment compared with a batch process.…”
Section: Introductionmentioning
confidence: 99%
“…Once the appropriate sample size is determined for the intended use of an analytical method, the integration time and number of co-adds of the PAT sensors need to be specified to meet the sampling needs of the process and product. 22…”
Section: Introductionmentioning
confidence: 99%